These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10229064)

  • 21. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.
    Rosebush PI; Hildebrand AM; Furlong BG; Mazurek MF
    J Clin Psychiatry; 1990 Sep; 51(9):357-62. PubMed ID: 2211547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurring episodes of Bell's mania after cerebrovascular accident.
    Bobo WV; Murphy MJ; Heckers SH
    Psychosomatics; 2009; 50(3):285-8. PubMed ID: 19567770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Benzodiazepines in the treatment of catatonia].
    Van Dalfsen AN; Van Den Eede F; Van Den Bossche B; Sabbe BG
    Tijdschr Psychiatr; 2006; 48(3):235-9. PubMed ID: 16956088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catatonic syndrome: importance of detection and treatment with lorazepam.
    Seethalakshmi R; Dhavale S; Suggu K; Dewan M
    Ann Clin Psychiatry; 2008; 20(1):5-8. PubMed ID: 18297580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent catatonia following epileptic seizures: a case report and systematic literature search.
    Verbraeken R; Luykx JJ
    BMC Psychiatry; 2018 Oct; 18(1):350. PubMed ID: 30373550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I; Colombo G; Furlanut M; Benetello P
    Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Schizophrenia With Catatonia Resistant to Lorazepam and Olanzapine Monotherapy But Responsive to Combination Treatment: Is It Time to Consider Using Select Second-Generation Antipsychotics Earlier in the Treatment Algorithm for This Patient Type?
    Spiegel DR; Glad R; Smith M; Raja U; Wade R; Johnson K
    Clin Neuropharmacol; 2019; 42(2):57-59. PubMed ID: 30762605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report.
    Grenier E; Ryan M; Ko E; Fajardo K; John V
    J Nerv Ment Dis; 2011 Dec; 199(12):987-8. PubMed ID: 22134459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical predictors of response to treatment in catatonia.
    Narayanaswamy JC; Tibrewal P; Zutshi A; Srinivasaraju R; Math SB
    Gen Hosp Psychiatry; 2012; 34(3):312-6. PubMed ID: 22387048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ECT for lorazepam-refractory catatonia.
    Yeung PP; Milstein RM; Daniels DC; Bowers MB
    Convuls Ther; 1996 Mar; 12(1):31-5. PubMed ID: 8777651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of catatonia with lorazepam].
    González-Seijo JC; Ramos Vicente YM; Lastra Martínez I; Carbonell Masía C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1993; 21(3):90-4. PubMed ID: 8101421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous lorazepam in neuroleptic-induced catatonia.
    Fricchione GL; Cassem NH; Hooberman D; Hobson D
    J Clin Psychopharmacol; 1983 Dec; 3(6):338-42. PubMed ID: 6139391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychogenic catatonia treated with lorazepam.
    Ripley TL; Millson RC
    Am J Psychiatry; 1988 Jun; 145(6):764-5. PubMed ID: 3369569
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid relief of catatonia in mood disorder by lorazepam and diazepam.
    Huang YC; Lin CC; Hung YY; Huang TL
    Biomed J; 2013; 36(1):35-9. PubMed ID: 23515153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramuscular lorazepam in catatonia in patients with acute renal failure: a report of two cases.
    Huang CE; Huang TL
    Chang Gung Med J; 2010; 33(1):106-9. PubMed ID: 20184802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catatonia: an open prospective series with carbamazepine.
    Kritzinger PR; Jordaan GP
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):251-7. PubMed ID: 11602030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.